Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.19.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Years Ended December 31,  
    2018     2017  
Research and development   $ 2,583,251     $ 884,032  
General and administrative     1,735,742       749,453  
Total   $ 4,318,993     $ 1,633,485  
Schedule of stock option activity
                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2016     4,652,497       1,908,883     $ 0.92     $ 0.41     $ 0.41       8.24     $ -  
Granted     1,316,000       -       -       -       -       -       -  
Exercised     (123,333 )     -       -       -       -       -       -  
Cancelled     (153,750 )     -       -       -       -       -       -  
Balance – December 31, 2017     5,691,414       3,124,941     $ 1.16     $ 0.73     $ 0.73       6.87     $ -  
Granted     860,000       -       -       -       -       -       -  
Exercised     (602,533 )     -       -       -       -       -       -  
Cancelled     (460,599 )     -       -       -       -       -       -  
Balance – December 31, 2018     5,488,282       4,384,294     $ 2.10     $ 1.32     $ 1.32       5.80     $ 8,437,330  
Schedule of stock options outstanding and exercisable
Grant Price     Weighted Average     Total     Number   Weighted Average Remaining
From     To     Exercise Price     Outstanding     Exercisable   Contractual Term
$ 0.05     $ 2.02     $ 0.90       3,533,282     3,432,344    6.21 years
$ 2.40     $ 4.60     $ 2.87       1,202,000     627,208    8.38 years
$ 5.30     $ 8.86     $ 6.52       753,000     324,742    9.35 years
                  Totals       5,488,282     4,384,294    
Schedule of warrants activity
                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2016     6,681,051       6,618,551     $ 1.74     $ 1.74     $ 0.41       0.98     $ -  
Granted     3,618,053       -       -       -       -       -       -  
Exercised     (1,070,238 )     -       -       -       -       -       -  
Cancelled     (4,695,846 )     -       -       -       -       -       -  
Balance – December 31, 2017     4,533,020       4,517,395     $ 1.85     $ 1.85     $ 1.00       3.21     $ -  
Granted     780,500       -       -       -       -       -       -  
Exercised     (349,315 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – December 31, 2018     4,964,205       4,964,205     $ 2.39     $ 2.39     $ 1.14       2.27     $ 5,304,835